Antigen-Specific T Cells: Analyses of the Needles in the Haystack

Por Slansky, Jill E
Publicado em 2003

The Goldilocks Model for TCR—Too Much Attraction Might Not Be Best for Vaccine Design

Por Slansky, Jill E., Jordan, Kimberly R.
Publicado em 2010

Multiple Associations Between a Broad Spectrum of Autoimmune Diseases, Chronic Inflammatory Diseases and Cancer

Por FRANKS, ALEXIS L., SLANSKY, JILL E.
Publicado em 2012

Mimotope vaccine efficacy gets a "boost" from native tumor antigens

Por Buhrman, Jonathan D., Slansky, Jill E.
Publicado em 2013

Improving T cell responses to modified peptides in tumor vaccines

Por Buhrman, Jonathan D., Slansky, Jill E.
Publicado em 2013

Mobilizing the low-avidity T cell repertoire to kill tumors

Por McMahan, Rachel H., Slansky, Jill E.
Publicado em 2007

Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity

Por Waugh, Katherine A., Leach, Sonia M., Slansky, Jill E.
Publicado no Vaccines (Basel) (2015)

Tolerance of Tumor-Specific T cells in Melanoma Metastases

Por Waugh, Katherine A, Leach, Sonia M, Slansky, Jill E
Publicado no J Clin Cell Immunol (2016)

Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses()

Por Kemmler, Charles B., Clambey, Eric T., Kedl, Ross M., Slansky, Jill E.
Publicado em 2011

Vaccination of Mice with Baculovirus-Infected Insect Cells Expressing Antigenic Proteins

Por Jordan, Kimberly R., Crawford, Fran, Kappler, John W., Slansky, Jill E.
Publicado em 2009

Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens

Por Jordan, Kimberly R., McMahan, Rachel H., Kemmler, Charles B., Kappler, John W., Slansky, Jill E.
Publicado em 2010

Augmenting Anti-Tumor T Cell Responses to Mimotope Vaccination by Boosting with Native Tumor Antigens

Por Buhrman, Jonathan D., Jordan, Kimberly R., U’Ren, Lance, Sprague, Jonathan, Kemmler, Charles B., Slansky, Jill E.
Publicado em 2012

Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor

Por Buhrman, Jonathan D., Jordan, Kimberly R., Munson, Daniel J., Moore, Brandon L., Kappler, John W., Slansky, Jill E.
Publicado em 2013

Molecular profile of tumor-specific CD8+ T cell hypofunction in a transplantable murine cancer model()

Por Waugh, Katherine A., Leach, Sonia M., Moore, Brandon L., Bruno, Tullia C., Buhrman, Jonathan D., Slansky, Jill E.
Publicado no J Immunol (2016)

TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines

Por Jordan, Kimberly R., Buhrman, Jonathan D., Sprague, Jonathan, Moore, Brandon L., Gao, Dexiang, Kappler, John W., Slansky, Jill E.
Publicado em 2012

Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines

Por McMahan, Rachel H., McWilliams, Jennifer A., Jordan, Kimberly R., Dow, Steven W., Wilson, Darcy B., Slansky, Jill E.
Publicado em 2006

Age-dependent tolerance to an endogenous tumor-associated antigen

Por McWilliams, Jennifer A., Sullivan, Richard T., Jordan, Kimberly R., McMahan, Rachel H., Kemmler, Charles B., McDuffie, Marcia, Slansky, Jill E.
Publicado em 2008

Dendritic cell subsets require cis-activation for cytotoxic CD8 T cell induction

Por Desch, A. Nicole, Gibbings, Sophie L., Clambey, Eric T., Janssen, William J., Slansky, Jill E., Kedl, Ross M., Henson, Peter M., Jakubzick, Claudia
Publicado em 2014

Direct visualization of antigen-specific T cells: HTLV-1 Tax11–19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP pati...

Por Greten, Tim F., Slansky, Jill E., Kubota, Ryuji, Soldan, Samantha S., Jaffee, Elizabeth M., Leist, Thomas P., Pardoll, Drew M., Jacobson, Steven, Schneck, Jonathan P.
Publicado em 1998

B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

Por Tseng, Su-Yi, Otsuji, Mizuto, Gorski, Kevin, Huang, Xin, Slansky, Jill E., Pai, Sara I., Shalabi, Ahmed, Shin, Tahiro, Pardoll, Drew M., Tsuchiya, Haruo
Publicado em 2001